We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

223 hedge funds and large institutions have $1.3B invested in Exact Sciences in 2016 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 76 increasing their positions, 67 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

90.03% more ownership

Funds ownership: 0%90.03% (+90%)

13% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 67

1% less funds holding

Funds holding: 225223 (-2)

3% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 40

26% less capital invested

Capital invested by funds: $1.76B → $1.3B (-$458M)

44% less call options, than puts

Call options by funds: $10.6M | Put options by funds: $19M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
223
Holders Change
-2
Holders Change %
-0.89%
% of All Funds
5.57%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
39
Increased
76
Reduced
67
Closed
40
Calls
$10.6M
Puts
$19M
Net Calls
-$8.4M
Net Calls Change
-$4M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$110M +$5.03M +311,306 +4%
William Blair Investment Management
2
William Blair Investment Management
Illinois
$78.7M +$15.2M +939,270 +19%
State Street
3
State Street
Massachusetts
$74.2M +$9.41M +582,802 +12%
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$62.3M -$12.7M -785,229 -14%
Citigroup
5
Citigroup
New York
$60.4M +$16.4M +1,015,756 +29%
Primecap Management
6
Primecap Management
California
$60M
GGHC
7
Gilder Gagnon Howe & Co
New York
$49.6M -$3.03M -187,449 -5%
BFA
8
BlackRock Fund Advisors
California
$42.4M +$7.99M +494,982 +18%
ACH
9
ArrowMark Colorado Holdings
Colorado
$41.4M +$18.4M +1,141,786 +58%
GIM
10
Granahan Investment Management
Massachusetts
$41.1M +$18.9M +1,172,050 +62%
BIT
11
BlackRock Institutional Trust
California
$40.2M +$4.63M +286,902 +11%
JP Morgan Chase
12
JP Morgan Chase
New York
$33.6M -$514K -31,842 -1%
ZCI
13
Zevenbergen Capital Investments
Washington
$31.1M -$1.09M -67,505 -3%
Norges Bank
14
Norges Bank
Norway
$25.2M -$2.63M -162,986 -8%
UBS AM
15
UBS AM
Illinois
$25.1M -$1.07M -66,090 -3%
Capital World Investors
16
Capital World Investors
California
$23.4M
Fidelity Investments
17
Fidelity Investments
Massachusetts
$23.2M -$8.1M -501,827 -22%
WA
18
Wasatch Advisors
Utah
$22.5M -$579K -35,848 -2%
EAM
19
Eagle Asset Management
Florida
$20.9M +$13.4M +832,133 +114%
O
20
OppenheimerFunds
New York
$20M -$10M -621,665 -29%
ECP
21
Elk Creek Partners
Colorado
$18.9M +$4.16M +257,954 +22%
Northern Trust
22
Northern Trust
Illinois
$18.1M +$687K +42,578 +3%
O
23
OrbiMed
New York
$12.7M -$2.45M -151,600 -14%
Millennium Management
24
Millennium Management
New York
$12.1M -$1.14M -70,911 -7%
CWAM
25
Columbia Wanger Asset Management
Illinois
$11.5M +$4.94M +305,699 +55%

EXAS Hedge Fund Activity: Q4 2016 in Review

223 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2016, worth a combined $1.3B — down 26% from $1.76B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of EXAS and 39 opened new positions — a net loss of 1 holder — while 67 trimmed existing stakes and 76 added.

The largest buyer was Granahan Investment Management, adding an estimated $18.9M. The largest seller was Lord, Abbett & Co, cutting an estimated $28.5M.

  • 223 institutional investors held Exact Sciences (EXAS) as of Q4 2016, down from 225 in Q3 2016.
  • Funds reported $1.3B of Exact Sciences stock for Q4 2016, down 26% quarter-over-quarter.
  • 39 funds opened new Exact Sciences positions in Q4 2016 and 40 closed out, a net change of -1 holder.
  • The largest Exact Sciences buyer in Q4 2016 was Granahan Investment Management, an estimated $18.9M added.
  • The largest Exact Sciences seller in Q4 2016 was Lord, Abbett & Co, an estimated $28.5M sold.

Based on aggregated 13F filings for Q4 2016.